- Home
- NOTE vs ME Comparison
NOTE vs ME Comparison
Compare NOTE & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- ME
- Stock Information
- Founded
- NOTE 2013
- ME 2006
- Country
- NOTE United States
- ME United States
- Employees
- NOTE N/A
- ME N/A
- Industry
- NOTE EDP Services
- ME Precision Instruments
- Sector
- NOTE Technology
- ME Health Care
- Exchange
- NOTE Nasdaq
- ME Nasdaq
- Market Cap
- NOTE 132.5M
- ME 113.9M
- IPO Year
- NOTE N/A
- ME N/A
- Fundamental
- Price
- NOTE $1.05
- ME $3.24
- Analyst Decision
- NOTE Strong Buy
- ME Hold
- Analyst Count
- NOTE 6
- ME 1
- Target Price
- NOTE $3.30
- ME $9.40
- AVG Volume (30 Days)
- NOTE 1.1M
- ME 393.2K
- Earning Date
- NOTE 11-12-2024
- ME 02-05-2025
- Dividend Yield
- NOTE N/A
- ME N/A
- EPS Growth
- NOTE N/A
- ME N/A
- EPS
- NOTE N/A
- ME N/A
- Revenue
- NOTE $125,062,000.00
- ME $193,260,000.00
- Revenue This Year
- NOTE N/A
- ME $21.93
- Revenue Next Year
- NOTE $4.01
- ME $17.31
- P/E Ratio
- NOTE N/A
- ME N/A
- Revenue Growth
- NOTE N/A
- ME N/A
- 52 Week Low
- NOTE $0.75
- ME $2.66
- 52 Week High
- NOTE $2.27
- ME $19.38
- Technical
- Relative Strength Index (RSI)
- NOTE 56.71
- ME 38.88
- Support Level
- NOTE $0.81
- ME $3.26
- Resistance Level
- NOTE $0.95
- ME $3.50
- Average True Range (ATR)
- NOTE 0.12
- ME 0.35
- MACD
- NOTE 0.03
- ME 0.04
- Stochastic Oscillator
- NOTE 67.57
- ME 12.26
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of global policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With expert analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.